Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | 1,517,855 | N/A | -17,273 | -29,192 | -32,535 |
Depreciation Amortization | 46,394 | N/A | 5 | 24 | 43 |
Accounts receivable | 111,529 | N/A | N/A | N/A | N/A |
Other Working Capital | 490,213 | N/A | -241 | 97 | -626 |
Other Operating Activity | -547,674 | 0 | 1,928 | 3,742 | 3,784 |
Operating Cash Flow | $1,618,317 | $N/A | $-15,581 | $-25,329 | $-29,334 |
Cash Flows From Investing Activities | |||||
PPE Investments | -269,593 | N/A | N/A | N/A | N/A |
Purchase Of Investment | -176,983 | N/A | N/A | N/A | N/A |
Sale Of Investment | 750,000 | N/A | N/A | N/A | N/A |
Investing Cash Flow | $303,424 | $N/A | $0 | $0 | $0 |
Cash Flows From Financing Activities | |||||
Debt Repayment | -294,000 | N/A | N/A | N/A | N/A |
Common Stock Issued | N/A | N/A | 2,876 | 102 | 147 |
Dividend Paid | -1,083,052 | N/A | N/A | N/A | N/A |
Other Financing Activity | -2,049 | 0 | 0 | 0 | 0 |
Financing Cash Flow | $-1,379,101 | $N/A | $2,876 | $102 | $147 |
Beginning Cash Position | 1,381,571 | N/A | 21,393 | 46,620 | 75,807 |
End Cash Position | 1,924,211 | N/A | 8,688 | 21,393 | 46,620 |
Net Cash Flow | $542,640 | $N/A | $-12,705 | $-25,227 | $-29,187 |
Free Cash Flow | |||||
Operating Cash Flow | 1,618,317 | N/A | -15,581 | -25,329 | -29,334 |
Capital Expenditure | -269,593 | N/A | 0 | 0 | 0 |
Free Cash Flow | 1,348,724 | 0 | -15,581 | -25,329 | -29,334 |